In obese AT, the plasma concentrations of adiponectin and IL-10 are significantly reduced [72], which results in a weakened anti-inflammatory effect, thus exacerbating the development of AT inflammation. The gene discussed is ADIPOQ; the disease is ataxia telangiectasia.